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Background: Burkholderia pseudomallei and Burkholderia mallei are gram-negative pathogens responsible for the
diseases melioidosis and glanders, respectively. Both species cause disease in humans and animals and have been
designated as category B select agents by the Centers for Disease Control and Prevention (CDC). Burkholderia
thailandensis is a closely related bacterium that is generally considered avirulent for humans. While it can cause
disease in rodents, the B. thailandensis 50% lethal dose (LD50) is typically≥ 10
4-fold higher than the B. pseudomallei
and B. mallei LD50 in mammalian models of infection. Here we describe an alternative to mammalian hosts in the
study of virulence and host-pathogen interactions of these Burkholderia species.
Results: Madagascar hissing cockroaches (MH cockroaches) possess a number of qualities that make them desirable
for use as a surrogate host, including ease of breeding, ease of handling, a competent innate immune system, and
the ability to survive at 37°C. MH cockroaches were highly susceptible to infection with B. pseudomallei, B. mallei
and B. thailandensis and the LD50 was <10 colony-forming units (cfu) for all three species. In comparison, the LD50
for Escherichia coli in MH cockroaches was >105 cfu. B. pseudomallei, B. mallei, and B. thailandensis cluster 1 type VI
secretion system (T6SS-1) mutants were all attenuated in MH cockroaches, which is consistent with previous
virulence studies conducted in rodents. B. pseudomallei mutants deficient in the other five T6SS gene clusters,
T6SS-2 through T6SS-6, were virulent in both MH cockroaches and hamsters. Hemocytes obtained from MH
cockroaches infected with B. pseudomallei harbored numerous intracellular bacteria, suggesting that this facultative
intracellular pathogen can survive and replicate inside of MH cockroach phagocytic cells. The hemolymph extracted
from these MH cockroaches also contained multinuclear giant cells (MNGCs) with intracellular B. pseudomallei,
which indicates that infected hemocytes can fuse while flowing through the insect’s open circulatory
system in vivo.
Conclusions: The results demonstrate that MH cockroaches are an attractive alternative to mammals to study
host-pathogen interactions and may allow the identification of new Burkholderia virulence determinants. The
importance of T6SS-1 as a virulence factor in MH cockroaches and rodents suggests that the primary role of this
secretion system is to target evasion of the innate immune system.
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Burkholderia mallei is an obligate parasite of horses,
mules and donkeys and no other natural reservoir is known
[1]. The organism is a nonmotile gram-negative bacillus
that is closely related to Burkholderia pseudomallei and
Burkholderia thailandensis. B. pseudomallei is a pathogenic
microbe that causes the glanders-like disease melioidosis
[2] and B. thailandensis is a weakly pathogenic soil sapro-
phyte [3]. While a handful of Burkholderia virulence deter-
minants have been identified using rodent models of
infection [4], research on the molecular mechanism(s) of
pathogenesis is still a fertile area. B. mallei, B. pseudomallei,
and B. thailandensis are able to survive and replicate inside
phagocytic cells in a process that involves escape from the
endocytic vacuole, replication in the cytosol, intra- and
intercellular spread by actin polymerization, and fusion
with uninfected cells to form multinucleated giant cells
(MNGCs) [4]. Gram-negative pathogens often use secretion
systems to deliver virulence factors to the cytosol of host
cells, where they modulate cell physiology to favor the mi-
crobe. The exploitation of host phagocytic cells by B.
pseudomallei involves two type III secretion systems
(T3SS-1 & T3SS-3) [5–7], a type V secretion system
(BimA) [8], and the cluster 1 type VI secretion system
(T6SS-1) [9]. T6SS-1, occasionally referred to as tss-5
[10], is also important for host cell interactions and
virulence in B. mallei and B. thailandensis [11,12].
Small mammal models of infection have long been
employed to characterize virulence factors of bacterial
pathogens, but over the last decade there has been an
increase in the use of surrogate hosts to study the patho-
genic mechanisms of bacteria [13,14]. Several surrogate
hosts have been used as alternatives to mammals to
study virulence factors and host-pathogen interactions
with B. pseudomallei, B. mallei, and B. thailandensis, in-
cluding Galleria mellonella larvae (wax worms) [15,16],
Dictyostelium discoideum (phagocytic amoeba) [17],
Caenorhabditis elegans (soil nematode) [18–20], and
Solanum lycopersicum (tomato plantlets) [21]. These al-
ternative hosts have allowed the identification of new
Burkholderia virulence determinants and have con-
firmed the importance of virulence factors previously
characterized using rodent models of infection.
Insects are popular alternatives to mammalian hosts
in large-scale screening studies, owing largely to the
high degree of similarity between the innate immune
systems of insects and mammals [22]. In both, the rec-
ognition of pathogen-associated molecular patterns
(PAMPs) by Toll receptors (insects) and Toll-like recep-
tors (mammals) results in the production of antimicro-
bial peptides [23]. Furthermore, insect hemocytes and
mammalian neutrophils can both engulf and kill most
invading microorganisms [24]. Insects are also afforded
protection from microorganisms through the coagulationand melanization of hemolymph, but they do not have an
adaptive immune system.
In addition to biological similarities, several logistical
issues contribute to the recent adoption of insects as al-
ternative hosts for bacterial pathogens. Insects can be
readily obtained, housed, and cared for at considerable
cost savings compared to mammals. Moreover, the use
of insects is not governed by animal use regulations or
committees and even very large-scale experiments
using insects are considered ethically acceptable. As a
possible insect alternative to mammalian models of in-
fection, we tested several B. pseudomallei, B. mallei,
and B. thailandensis strains against juvenile Madagas-
car hissing cockroaches (MH cockroaches) obtained
from a commercial vendor (Carolina Biological Supply
Company). MH cockroaches are readily available, easily
cultured, and reproduce rapidly. They are larger than
wax moth larvae, slow moving compared to other spe-
cies of cockroaches, and have a substantive carapace.
These characteristics make them easier to manipulate
and inoculate with known numbers of bacteria com-
pared with other species of insects commonly used for
similar studies. MH cockroaches thrive at 37°C, a char-
acteristic that is essential for the analysis of mammalian
pathogens.
In this study, we found the MH cockroach to be a suit-
able surrogate host for B. pseudomallei, B. mallei, and B.
thailandensis. Burkholderia type VI secretion system
mutants were attenuated in MH cockroaches, which is
consistent with what is seen in rodent models of infec-
tion [9,25]. B. pseudomallei multiplied inside MH cock-
roach hemocytes and may be the primary mechanism by
which this pathogen avoids elimination by the MH cock-
roach innate immune system. The results suggest that
MH cockroaches are a good alternative to mammals for
the study of Burkholderia species and possibly other
mammalian pathogens.
Results and discussion
B. pseudomallei is virulent in the MH cockroach and
T6SS-1 mutants exhibit attenuated virulence
In an attempt to determine if the MH cockroach might
serve as a surrogate host for B. pseudomallei, we chal-
lenged juvenile MH cockroaches (Figure 1) with K96243
and T6SS mutant derivatives. T6SS-1 is a critical virulence
determinant for B. pseudomallei in the hamster model of
infection [9], while T6SS-2, T6SS-3, T6SS-4, T6SS-5, and
T6SS-6 are dispensable for virulence in hamsters. Groups
of eight MH cockroaches were challenged by the intra-
abdominal route with 101-105 bacteria and deaths were
recorded for 5 days at 37°C (Figure 2).
Figure 2A shows that only one MH cockroach sur-
vived for 5 days after challenge with 101 B. pseudomallei
K96243 (Bp), demonstrating that the 50% lethal dose
Figure 1 A representative juvenile Madagascar hissing
cockroach used as a surrogate host for B. pseudomallei, B.
mallei, and B. thailandensis infection studies. The black arrows
show the locations where bacteria were inoculated into the dorsal
abdominal section of the MH cockroach, between the third and the

























Figure 2 B. pseudomallei is virulent for the MH cockroach and T6SS-1
challenged by the intra-abdominal route of infection and MH cockroach de
103 cfu. (D) 104 cfu. (E) 105 cfu. Bp, K96243; Bp Δhcp1, DDS1498A; Bp ΔvgrG
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the hamster model of infection was <10 bacteria [9]. B.
pseudomallei Δhcp1 is a derivative of K96243 that lacks
the essential tail tube component of the T6SS-1 struc-
tural apparatus (Hcp1) and is highly attenuated in the
hamster [9,26]. B. pseudomallei Δhcp1 was also attenu-
ated in the MH cockroach (Figure 2A-E) and the LD50
was ~ 2 x 102 bacteria on day 5, which was >20 times
higher than the K96243 LD50 (Table 1). In addition, a
dose response was readily apparent with this strain. As
the challenge dose increased from 101 to 105 bacteria,
the number and rate of MH cockroach deaths increased
accordingly (Figure 2A-E). It took a challenge dose of
104 Δhcp1 to kill all eight MH cockroaches, whereas the
minimum lethal dose for K96243 was only 102 bacteria
(Figure 2). The results demonstrate that B. pseudomallei
is highly virulent in MH cockroaches and that T6SS-1 is
a critical virulence factor in this insect host. Further-
















mutants are attenuated. Groups of eight MH cockroaches were
aths were monitored for 5 days at 37°C. (A) 101 cfu. (B) 102 cfu. (C)
1-5’, DDS1503-1A; Bp ΔvgrG1-3’, DDS1503-2A.
Table 1 Relative virulence of bacterial strains in Syrian













DDS1498A (Δhcp1) >1000 207
DDS0518A (Δhcp2) <10 <10
DDS2098A (Δhcp3) <10 <10
DDS0171A (Δhcp4) <10 <10
DDS0099A (Δhcp5) <10 <10
DDL3105A (Δhcp6) <10 <10
DDS1503-1A (ΔvgrG1-5’) 102 <10





DDA0742 (Δhcp1) >103 >103
B. thailandensis
DW503 ND <10
DDII0868 (Δhcp1) ND >103
a LD50, 50% lethal dose [9,25,33];
b ND, not determined.
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the hamster (Table 1).
B. pseudomallei ΔvgrG1-5’ and ΔvgrG1-3’ are K96243
derivatives that have deletions within the gene encoding
the tail spike protein (VgrG1) of the T6SS-1 structural
apparatus [9,26]. These mutants were more virulent than
B. pseudomallei Δhcp1 in the hamster model of infection
[9], but were less virulent than K96243 (Table 1). There
was no difference in the LD50 of ΔvgrG1-5’, ΔvgrG1-3’,
and K96243 in MH cockroaches (Table 1), however,
there was a slight but not statistically significant differ-
ence in the time to death with these strains. In general,
it took longer for MH cockroaches infected with
ΔvgrG1-5’ and ΔvgrG1-3’ to die relative to K96243
(Figure 2A-C). Thus, these strains appear to have an
intermediate virulence phenotype in both MH cock-
roaches and in hamsters (Table 1 and Figure 2).
We next examined the relative virulence of the B. pseu-
domallei Δhcp2, Δhcp3, Δhcp4, Δhcp5, and Δhcp6mutants
in MH cockroaches [9]. These mutants are each deficient
in one of the other five T6SSs present in B. pseudomallei
and all are virulent in the hamster (Table 1). Figure 3shows that these strains are also virulent in the MH cock-
roach and all exhibit a clear dose response. The majority
of MH cockroaches infected with a challenge dose of 101
bacteria were dead by day 3 (Figure 3A), but most were
dead by day 1 with a challenge dose of 105 bacteria
(Figure 3E). Interestingly, the LD50 results with these
strains are remarkably similar in both MH cockroaches
and hamsters (Table 1).
The virulence of two additional isolates of B. pseudo-
mallei and two isolates of Escherichia coli were also tested
in the MH cockroach. The LD50s of B. pseudomallei
1026b and MSHR305 were <10 bacteria and the LD50s
for E. coli MC4100 and B/r were >105 bacteria, the high-
est dose tested (Table 1). The results suggest that viru-
lence for the MH cockroach is common among B.
pseudomallei isolates and that not all gram-negative bac-
teria are pathogenic for this surrogate host (Table 1).
Taken together, the results demonstrate that B.
pseudomallei is highly virulent in the MH cockroach
and indicate that this insect might serve as a surrogate
host for high throughput virulence screening assays. In
addition, the MH cockroach challenge results are con-
sistent with what is seen in the hamster model of infec-
tion and suggest that the primary function of the T6SS-1
is to evade the innate immune system.
The MH cockroach can serve as a surrogate host for
B. mallei and B. thailandensis
We also evaluated the virulence of B. mallei and B.
thailandensis in the MH cockroach. The LD50s for B.
mallei SR1 (Bm) and B. thailandensis DW503 (Bt) were
< 10 bacteria (Table 1) and the number and rate of
deaths increased as the challenge dose increased from
101 to 103 bacteria (Figure 4). Interestingly, B. mallei
killed the MH cockroaches at a slower rate than B.
thailandensis (and B. pseudomallei). It took only 2 days
for B. thailandensis to kill 75% of the MH cockroaches
with a dose of 101 bacteria, whereas it took B. mallei
5 days (Figure 4A). Similar trends were apparent with
challenge doses of 102 and 103 bacteria (Figure 4B
and C). B. mallei does not kill rodents as quickly as
B. pseudomallei and it is more fastidious than B.
pseudomallei and B. thailandensis, so it may not be too
surprising that it took longer to kill MH cockroaches [4].
These experiments demonstrate that B. mallei and B.
thailandensis are both virulent in the MH cockroach and
suggest that the MH cockroach might serve as a surrogate
host for these bacterial species.
As mentioned above, B. thailandensis is considered
to be avirulent in humans and exhibits a higher LD50
in mammalian models of infection than B. mallei and
B. pseudomallei. Mammals, unlike MH cockroaches,
possess both an innate and an acquired immune sys-




































Figure 3 B. pseudomallei T6SS-2, T6SS-3, T6SS-4, T6SS-5, and T6SS-6 mutants are virulent in the MH cockroach. (A) 101 cfu. (B) 102 cfu.
(C) 103 cfu. (D) 104 cfu. (E) 105 cfu. Bp, K96243; Bp Δhcp2, DDS0518A; Bp Δhcp3, DDS2098A; Bp Δhcp4, DDS0171A; Bp Δhcp5, DDS0099A; Bp
Δhcp6, DDL3105A.
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immune system plays an important role in defence
against B. thailandensis. B. mallei and B. pseudomallei,
on the other hand, may have developed mechanisms to
subvert the acquired immune response in mammalian
species.
T6SS-1 is a critical virulence determinant for B. mallei
in the hamster model of infection [25] and for B.
thailandensis in the C57BL/6 mouse model of infection
[27]. We challenged MH cockroaches with B. mallei and
B. thailandensis hcp1 mutants and found that they were
highly attenuated in this surrogate host (Table 1 and
Figure 4). The LD50s for B. mallei Δhcp1 and B.
thailandensis hcp1- were> 103 bacteria on day 5, which
was at least 100 times higher than their respective par-
ental strains (Table 1 and Figure 4). The B. mallei results
were indistinguishable from what was previously describedfor SR1 and Δhcp1 using the hamster model of infection
[25]. While the B. thailandensis strains used in this study
have not been tested in hamsters, a B. thailandensis T6SS-
1 mutant was recently shown to be avirulent in C57BL/6
mice by the aerosol route of infection [27]. Interestingly,
MyD88−/− mice were susceptible to the B. thailandensis
T6SS-1 mutant, which suggests that T6SS-1 plays a role
in evading the innate immune response [27]. The fact
that B. thailandensis hcp1- was attenuated in an insect
host, which lacks an adaptive immune response, further
supports the notion that the function of the T6SS-1 is
to evade the eukaryotic innate immune system.
B. pseudomallei replicates inside MH cockroach
hemocytes
Hemocytes are a key component of the MH cockroach






















Figure 4 B. mallei and B. thailandensis are virulent for the MH
cockroach and their T6SS-1 mutants are attenuated. (A) 101 cfu.
(B) 102 cfu. (C) 103 cfu. Bm, SR1; Bm Δhcp1, DDA0742; Bt, DW503; Bt
Δhcp1, DDII0868.
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to gain an upper hand in the host-pathogen interaction.
A group of eight MH cockroaches were infected with ~
103 B. pseudomallei K96243 and closely monitored for
48 h. MH cockroaches that appeared weak and lethargic
were immediately separated from the others and
hemolymph was obtained. The MH cockroach hemo-
lymph, which contains phagocytic hemocytes, was fixed
and stained with DAPI. Figure 5A shows a representative
field containing the blue-staining nuclei from multiple
hemocytes. As expected, the non-nuclear regions of
most hemocytes could not be visualized with this fluor-
escent DNA stain. Interestingly, each field also contained
one or two hemocytes in which the nucleus and the sur-
rounding cytosol could be easily visualized (Figure 5A,
white arrows). We speculated that these particular
hematocytes might contain cytosolic B. pseudomallei
and we stained the hemolymph with a polyclonal anti-
body that reacts with B. pseudomallei. Figure 5B and
5 C show a representative micrograph of a hematocyte
engorged with cytosolic B. pseudomallei, suggesting that
the bacteria are multiplying to high numbers inside
these cells. Free bacteria can also be visualized in the
hemolymph outside the hemocyte, but it is unclear if
these cells are alive or dead (Figure 5B and 5C). Some
infected hemocytes appear to have multiple nuclei and
may be multinucleated giant cells (MNGCs) (Figure 5).
MNGC have been observed in cases of human melioid-
osis [28] and are often formed when B.pseudomallei
infects murine macrophage-like cell lines in vitro [9].
The formation of B. pseudomallei-induced MNGCs
in vivo in MH cockroaches is an exciting finding and
indicates that MNGCs can form in non-adherent cells
freely flowing within the hemolymph.
Based on these results, we hypothesize that B.
pseudomallei is able to survive the innate immune sys-
tem of the MH cockroach by establishing an intracellu-
lar niche within the hemocyte. Infected hemocytes
harboring numerous cytosolic bacteria may fuse with
uninfected hemocytes to form MNGCs, which may serve
as a reservoir for continued bacterial replication and
protection from the antimicrobial peptides present in
the surrounding hemolymph. The amplification of bac-
teria within phagocytic hemocytes, and their subsequent
release, may eventually overwhelm the MH cockroach
and lead to death.
Conclusions
Our findings indicate that the Madagascar hissing cock-
roach can serve as a surrogate host for the analysis of
host-pathogen interactions with B. pseudomallei, B.
mallei, and B. thailandensis. Using this system, we were
able to detect virulence differences between parental
strains and T6SS-1 mutants that were consistent with
Figure 5 B. pseudomallei multiplies inside MH cockroach
hemocytes. Panel A is a representative micrograph of hemolymph
obtained from a MH cockroach infected with B. pseudomallei K96243
and stained with DAPI. The white arrows show hemocytes that
harbor intracellular B. pseudomallei. The white scale bar is 100 μm.
Panels B and C show a higher magnification of a B. pseudomallei-
infected hemocyte using bright field microscopy (B) and stained
with DAPI and a Burkholderia-specific rabbit polyclonal antibody (C).
The secondary antibody used, Alexa Fluor 588 goat anti-rabbit IgG,
stained B. pseudomallei green. The magnified inset in C shows
individual bacilli within the hemocyte cytosol and the white arrows
show extracellular bacteria in the hemolymph. The white scale bars
in B and C are 20 μm. The results are representative images from
eight MH cockroaches infected with ~ 103 cfu of B. pseudomallei
K96243.
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pseudomallei K96243 demonstrated the ability to multi-
ply inside insect hemocytes and form MNGCs, which
may be the primary mechanism by which it avoids killing
by the MH cockroach innate immune system. The MH
cockroach will probably be useful for high throughput
virulence screening assays with these Burkholderia spe-
cies as well as other bacterial pathogens.
Methods
Bacterial strains, plasmids, and growth conditions
The bacterial strains and plasmids used in this study are
described in Table 2. E. coli, B. pseudomallei, and B.
thailandensis were grown at 37°C on Luria-Bertani (Len-
nox) agar (LB agar) or in LB broth. When appropriate,
antibiotics were added at the following concentrations:
15 μg of gentamicin (Gm), 25 μg of streptomycin (Sm),
and 25 μg of kanamycin (Km) per ml for E. coli and
25 μg of polymyxin B (Pm) and 25 μg of Gm per ml for
B. thailandensis. B. mallei was grown at 37°C on LB agar
with 4% glycerol or in LB broth with 4% glycerol. All
bacterial strains were grown in broth for ~ 18 h with
constant agitation at 250 revolutions per minute.
Phosphate-buffered saline (PBS) was used to make serial
dilutions of saturated bacterial cultures and the number
of cfu present in the starting culture were determined by
spreading 100 μl aliquots onto agar media and incuba-
ting for 24–48 h. A 20-mg/ml stock solution of
the chromogenic indicator 5-bromo-4-chloro-3-indolyl-
b-D-galactoside (X-Gal) was prepared in N,N-dimethyl-
formamide, and 40 μl was spread onto the surface of
plate medium for blue/white screening in E. coli TOP10.
All manipulations with B. pseudomallei and B. mallei
were carried out in class II and class III microbiological
safety cabinets located in designated biosafety level 3
(BSL-3) laboratories.
PCR
The two deoxyribonucleotide primers used for PCR ampli-
fication of an internal gene fragment of B. thailandensis
BTH_II0868 (hcp1) were purchased from Invitrogen
(Frederick, MD) and designated II0868-up (5’-AGGGCAA
GATTCTCGTCCAG-3’) and II0868-dn (5’-TCTCGTACGT
GAACGATACG-3’). The PCR product was sized and iso-
lated using agarose gel electrophoresis, cloned using the
pCR2.1-TOPO TA Cloning Kit (Invitrogen), and trans-
formed into chemically competent E. coli TOP10. PCR
amplification was performed in a final reaction volume of
100 μl containing 1X Taq PCR Master Mix (Qiagen),
1 μM oligodeoxyribonucleotide primers, and approxi-
mately 200 ng of B. thailandensis DW503 genomic DNA.
PCR cycling was performed using a PTC-150 MiniCycler
with a Hot Bonnet accessory (MJ Research, Inc.) and
heated to 97°C for 5 min. This was followed by 30 cycles
Table 2 Strains and plasmids used in this study
Strain or plasmid Relevant characteristicsa Source or reference
E. coli
TOP10 General cloning and blue/white screening Invitrogen
S17-1 Mobilizing strain with transfer genes of RP4 integrated
on chromosome; Smr, Pms
[34]
MC4100 K-12 laboratory strain [35]
B/r B laboratory strain [36]
B. pseudomallei
K96243 Isolated in Thailand from a diabetic patient with a clinical
history of short incubation, septicemic infection, and rapid progression to death
[37]
DDS1498A K96243 derivative harboring a 162-bp in-frame deletion mutation in hcp1 (Δhcp1) [9]
DDS0518A K96243 derivative harboring a 303-bp in-frame deletion mutation in hcp2 (Δhcp2) [9]
DDS2098A K96243 derivative harboring a 186-bp in-frame deletion mutation in hcp3 (Δhcp3) [9]
DDS0171A K96243 derivative harboring a 321-bp in-frame deletion mutation in hcp4 (Δhcp4) [9]
DDS0099A K96243 derivative harboring a 192-bp in-frame deletion mutation in hcp5 (Δhcp5) [9]
DDL3105A K96243 derivative harboring a 216-bp in-frame deletion mutation in hcp6 (Δhcp6) [9]
DDS1503-1A K96243 derivative harboring a deletion of the 743-bp StuI fragment at the 5’ end of
vgrG1 (ΔvgrG1-5’)
[9]
DDS1503-2A K96243 derivative harboring a deletion of the 894-bp PstI fragment at the 3’ end of
vgrG1 (ΔvgrG1-3’)
[9]
1026b Isolated in Thailand from a human case of septicemic melioidosis with skin, soft tissue,
and spleen involvement
[30]
MSHR305 Isolated from the brain of a fatal human melioidosis encephalomyelitis case in Australia [38,39]
B. mallei
SR1 ATCC 23344 sucrose-resistant derivative [40]




DW503 E264 derivative; Δ(amrR-oprA) (Gms) rpsL (Smr) [41]
DDII0868 DW503::pGSV3-0868; Gmr; hcp1- This study
Plasmids
pCR2.1-TOPO 3,931-bp TA vector; pMB1 oriR; Kmr Invitrogen
pCR2.1-0868 pCR2.1-TOPO containing 342-bp PCR product generated with II0868-up
and II0868-dn
This study
pGSV3 Mobilizabile Gmr suicide vector [42]
pGSV3-0868 pGSV3 derivative containing EcoRI insert from pCR2.1-0868 This study
a r, resistant; s, susceptible.
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55°C for 30 s, and 72°C for 1 min) and one cycle at 72°C
for 10 min.
DNA manipulation and plasmid conjugation
Restriction enzymes, Antarctic phosphatase, and T4
DNA ligase were purchased from Roche Molecular Bio-
chemicals and were used according to the manufac-
turer’s instructions. DNA fragments used in cloning
procedures were excised from agarose gels and purified
with a GeneClean III kit (Q  BIOgene). Bacterial gen-
omic DNA was prepared by a previously describedprotocol [29]. Plasmids were purified from overnight
cultures by using Wizard Plus SV Minipreps (Promega).
Plasmid pGSV3-0868 (Table 2) was electroporated into
E. coli S17-1 (12.25 kV/cm) and conjugated with B.
thailandensis for 8 h, as described elsewhere [30]. Pm
was used to counterselect E. coli S17-1 (pGSV3-0868).
MH cockroach housing and manipulation
Madagascar hissing cockroaches, Gromphadorhina
laevigata, were purchased from Carolina Biological
Supply Company (Burlington, NC) as 1–2 inch
nymphs (Figure 1) and were housed in the dark at
Fisher et al. BMC Microbiology 2012, 12:117 Page 9 of 10
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cage with a filtered top (Allentown Caging Equipment
Co., Inc., Allentown, NJ). The bottom of the cage was
lined with cocoa mulch and a thin layer of petroleum
jelly was spread around the top portion of the cage to
prevent MH cockroaches from climbing up the sides.
Dog food was spread on the bottom of the cage for
food and the top of a petri dish was inverted and filled
with water for drinking. On occasion, sliced apple
wedges were placed in the cage as an additional source
of food.
For bacterial infection experiments, 1.5-2 inch ju-
venile MH cockroaches were used (Figure 1). We also
tested larger MH cockroaches (> 3 inches) and they
displayed the same susceptibility as the juveniles (data
not shown). Bacteria were inoculated into the dorsal
abdominal section of MH cockroaches, between the
third and the fifth terga (from the posterior), using a
1 ml syringe fitted with a 3/8 inch, 26-gauge needle
(see Figure 1). The syringe was loaded into a Tridak
STEPPER series repetitive pipette (Tridak LLC, Tor-
rington, CT) and a 25 μl aliquot was injected into
MH cockroaches. A group of eight infected MH
cockroaches were placed in a 16-ounce plastic con-
tainer with a few pieces of dog food and 1–2 ml of
water. The containers were placed in a 37°C incuba-
tor and deaths were recorded for 5 days. Food and
water levels were checked daily and replenished if
needed. The LD50s were calculated 5 days postinfec-
tion according to the Reed-Muench method [31].
Extraction and staining of hemolymph from infected MH
cockroaches
Eight MH cockroaches were infected with ~ 103 B. pseu-
domallei K96243 and monitored daily as described
above. Hemolymph was extracted from MH cockroaches
that were lethargic and on the verge of death. Holding
the MH cockroach with its ventral side up, one hind
leg was folded up towards the head to expose the
membrane at the base of the leg. The membrane was
punctured with a 26-gauge needle and hemolymph
was immediately collected using a P200 Gilson
PIPETMAN. We used a pipette tip cut with scissors
approximately a 1/2 inch from the end to aid in up-
take of the viscous hemolyph. The amber-colored
hemolymph was transferred to a glass slide, allowed
to air dry, and then fixed with methanol. The samples
were initially stained with 4′, 6-diamidino-2-phenylindole
(DAPI) and viewed on a Nikon Eclipse TE2000-S inverted
microscope equipped with a Spot-RT digital camera
(Image Systems, Columbia, MD). Subsequently, the sam-
ples were incubated for 1 h with a 1:1000 dilution of rabbit
polyclonal Burkholderia antiserum [32] and then reacted
for 1 h with a 1:500 dilution of an Alexa Fluor 588 goatanti-rabbit IgG secondary antibody (Molecular Probes)
and visualized by fluorescence microscopy.
Abbreviations
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